Tarsus Bets Up To $800M On Alkeus In Retina Therapy Push
Tarsus Pharmaceuticals Inc. said Thursday it has agreed to acquire privately held Alkeus Pharmaceuticals Inc. for up to approximately $800 million, expanding the Irvine, California-based eye care company's pipeline into retinal...To view the full article, register now.
Already a subscriber? Click here to view full article